399 related articles for article (PubMed ID: 25153594)
1. Role of lncRNAs in prostate cancer development and progression.
Weiss M; Plass C; Gerhauser C
Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
[TBL] [Abstract][Full Text] [Related]
3. Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence.
Wang L; Han S; Jin G; Zhou X; Li M; Ying X; Wang L; Wu H; Zhu Q
Int J Oncol; 2014 Jun; 44(6):2041-9. PubMed ID: 24691949
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PlncRNA-1 accelerates the progression of prostate cancer by regulating PTEN/Akt axis.
Cui Z; Gao H; Yan N; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Wang Q; Kang W; Jin X
Aging (Albany NY); 2021 Apr; 13(8):12113-12128. PubMed ID: 33848262
[TBL] [Abstract][Full Text] [Related]
5. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
[TBL] [Abstract][Full Text] [Related]
6. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
8. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.
Wang D; Wan X; Zhang Y; Kong Z; Lu Y; Sun X; Huang Y; Ji C; Li D; Luo J; Gu W; Wang C; Li Y; Xu Y
Prostate; 2019 Sep; 79(12):1362-1377. PubMed ID: 31269242
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Das R; Feng FY; Selth LA
Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and androgen receptor signaling in the development and progression of castration-resistant prostate cancer.
Shiota M; Yokomizo A; Naito S
Free Radic Biol Med; 2011 Oct; 51(7):1320-8. PubMed ID: 21820046
[TBL] [Abstract][Full Text] [Related]
11. A feed-forward regulatory loop between androgen receptor and PlncRNA-1 promotes prostate cancer progression.
Fang Z; Xu C; Li Y; Cai X; Ren S; Liu H; Wang Y; Wang F; Chen R; Qu M; Wang Y; Zhu Y; Zhang W; Shi X; Yao J; Gao X; Hou J; Xu C; Sun Y
Cancer Lett; 2016 Apr; 374(1):62-74. PubMed ID: 26808578
[TBL] [Abstract][Full Text] [Related]
12. [Long non-coding RNAs in prostate cancer: An update].
Wu PG; Zhang YX
Zhonghua Nan Ke Xue; 2018 Aug; 24(8):735-739. PubMed ID: 30173435
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs in prostate cancer: overview and clinical implications.
Malik B; Feng FY
Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
[TBL] [Abstract][Full Text] [Related]
14. RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis.
Bai Y; Yang Y; Yan Y; Zhong J; Blee AM; Pan Y; Ma T; Karnes RJ; Jimenez R; Xu W; Huang H
Theranostics; 2019; 9(12):3459-3475. PubMed ID: 31281490
[No Abstract] [Full Text] [Related]
15. The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
Cui Z; Ren S; Lu J; Wang F; Xu W; Sun Y; Wei M; Chen J; Gao X; Xu C; Mao JH; Sun Y
Urol Oncol; 2013 Oct; 31(7):1117-23. PubMed ID: 22264502
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA PCGEM1 is regulated by androgen receptor activity in vivo.
Parolia A; Crea F; Xue H; Wang Y; Mo F; Ramnarine VR; Liu HH; Lin D; Saidy NR; Clermont PL; Cheng H; Collins C; Wang Y; Helgason CD
Mol Cancer; 2015 Feb; 14():46. PubMed ID: 25744782
[TBL] [Abstract][Full Text] [Related]
17. Novel lncRNA
Lingadahalli S; Jadhao S; Sung YY; Chen M; Hu L; Chen X; Cheung E
Mol Cancer Res; 2018 Dec; 16(12):1865-1878. PubMed ID: 30115758
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer-associated lncRNAs.
Mitobe Y; Takayama KI; Horie-Inoue K; Inoue S
Cancer Lett; 2018 Apr; 418():159-166. PubMed ID: 29330107
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.
Zhang Y; Pitchiaya S; Cieślik M; Niknafs YS; Tien JC; Hosono Y; Iyer MK; Yazdani S; Subramaniam S; Shukla SK; Jiang X; Wang L; Liu TY; Uhl M; Gawronski AR; Qiao Y; Xiao L; Dhanasekaran SM; Juckette KM; Kunju LP; Cao X; Patel U; Batish M; Shukla GC; Paulsen MT; Ljungman M; Jiang H; Mehra R; Backofen R; Sahinalp CS; Freier SM; Watt AT; Guo S; Wei JT; Feng FY; Malik R; Chinnaiyan AM
Nat Genet; 2018 Jun; 50(6):814-824. PubMed ID: 29808028
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
Xu YH; Deng JL; Wang G; Zhu YS
Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]